EDGAR Filing Documents for 0000950149-04-000715

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000950149-04-000715

Filing Date

2004-03-30

Accepted

2004-03-30 15:59:51

Documents

Period of Report

2003-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	f97652e10vk.htm	10-K	704925
3	EXHIBIT 21.1	f97652exv21w1.htm	EX-21.1	7797
4	EXHIBIT 23.1	f97652exv23w1.htm	EX-23.1	1195
5	EXHIBIT 31.1	f97652exv31w1.htm	EX-31.1	5717
6	EXHIBIT 31.2	f97652exv31w2.htm	EX-31.2	5116
7	EXHIBIT 32.1	f97652exv32w1.htm	EX-32.1	2064
8	EXHIBIT 32.2	f97652exv32w2.htm	EX-32.2	2067
9	GRAPHIC	f97652f9765205.gif	GRAPHIC	113422
	Complete submission text file	0000950149-04-000715.txt		844611

Mailing Address 9500 GILMAN DR UNIVERSITY OF CALIFORNIA LA JOLLA CA 92093-0663

Business Address 717 POTTER STREET, SUITE 100 BERKELEY CA 94710 5108485100

DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-50577 | Film No.: 04701040
SIC: 2834 Pharmaceutical Preparations